DrugCite
Search

PULMICORT RESPULES

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Pulmicort Respules Adverse Events Reported to the FDA Over Time

How are Pulmicort Respules adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Pulmicort Respules, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Pulmicort Respules is flagged as the suspect drug causing the adverse event.

Most Common Pulmicort Respules Adverse Events Reported to the FDA

What are the most common Pulmicort Respules adverse events reported to the FDA?

Dyspnoea
142 (4.62%)
Cough
106 (3.45%)
Asthma
75 (2.44%)
Drug Ineffective
72 (2.34%)
Medication Error
69 (2.24%)
Wheezing
66 (2.15%)
Pneumonia
55 (1.79%)
Dysphonia
52 (1.69%)
Psychomotor Hyperactivity
50 (1.63%)
Insomnia
41 (1.33%)
Rhinorrhoea
39 (1.27%)
Show More Show More
Dry Mouth
29 (.94%)
Nasopharyngitis
29 (.94%)
Tremor
28 (.91%)
Dysgeusia
25 (.81%)
Chest Discomfort
24 (.78%)
Rash
24 (.78%)
Chest Pain
23 (.75%)
Weight Increased
22 (.72%)
Diarrhoea
21 (.68%)
Headache
21 (.68%)
Muscle Spasms
21 (.68%)
Pyrexia
21 (.68%)
Weight Decreased
21 (.68%)
Abnormal Behaviour
20 (.65%)
Aggression
20 (.65%)
Dizziness
20 (.65%)
Fatigue
20 (.65%)
Bronchitis
19 (.62%)
Pruritus
19 (.62%)
Anxiety
18 (.59%)
Malaise
18 (.59%)
Nausea
18 (.59%)
Vomiting
18 (.59%)
Drug Administration Error
17 (.55%)
Heart Rate Increased
17 (.55%)
Irritability
17 (.55%)
Drug Dose Omission
16 (.52%)
Increased Upper Airway Secretion
16 (.52%)
Throat Irritation
16 (.52%)
Alopecia
15 (.49%)
Blood Glucose Increased
15 (.49%)
Chronic Obstructive Pulmonary Disea...
15 (.49%)
Incorrect Route Of Drug Administrat...
15 (.49%)
Oxygen Saturation Decreased
15 (.49%)
Respiratory Distress
15 (.49%)
Urticaria
15 (.49%)
Asthenia
14 (.46%)
Constipation
14 (.46%)
Ear Infection
14 (.46%)
Ill-defined Disorder
14 (.46%)
Nervousness
14 (.46%)
Oedema Peripheral
14 (.46%)
Off Label Use
14 (.46%)
Stomatitis
14 (.46%)
Feeling Abnormal
13 (.42%)
Abdominal Distension
12 (.39%)
Burning Sensation
12 (.39%)
Dental Caries
12 (.39%)
Increased Appetite
12 (.39%)
Vision Blurred
12 (.39%)
Wrong Technique In Drug Usage Proce...
12 (.39%)
Erythema
11 (.36%)
Oral Pain
11 (.36%)
Respiratory Rate Increased
11 (.36%)
Conjunctivitis
10 (.33%)
Crying
10 (.33%)
Fall
10 (.33%)
Glaucoma
10 (.33%)
Hypersensitivity
10 (.33%)
Lethargy
10 (.33%)
Loss Of Consciousness
10 (.33%)
Mood Altered
10 (.33%)
Oropharyngeal Pain
10 (.33%)
Pain In Extremity
10 (.33%)
Swelling Face
10 (.33%)
Candidiasis
9 (.29%)
Cataract
9 (.29%)
Death
9 (.29%)
Eye Disorder
9 (.29%)
Hypertension
9 (.29%)
Pulmonary Congestion
9 (.29%)
Sinusitis
9 (.29%)
Throat Tightness
9 (.29%)
Agitation
8 (.26%)
Chest X-ray Abnormal
8 (.26%)
Condition Aggravated
8 (.26%)
Drug Effect Decreased
8 (.26%)
Drug Ineffective For Unapproved Ind...
8 (.26%)
Epistaxis
8 (.26%)
Flushing
8 (.26%)
Hyperglycaemia
8 (.26%)
Oral Candidiasis
8 (.26%)
Pain
8 (.26%)
Palpitations
8 (.26%)
Restlessness
8 (.26%)
Thirst
8 (.26%)
Weight Gain Poor
8 (.26%)
Abdominal Pain Upper
7 (.23%)
Aphonia
7 (.23%)
Blood Glucose Decreased
7 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Pulmicort Respules, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Pulmicort Respules is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Pulmicort Respules

What are the most common Pulmicort Respules adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Pulmicort Respules, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Pulmicort Respules is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Pulmicort Respules According to Those Reporting Adverse Events

Why are people taking Pulmicort Respules, according to those reporting adverse events to the FDA?

Asthma
403
Chronic Obstructive Pulmonary Disea...
175
Emphysema
60
Dyspnoea
22
Wheezing
22
Cough
22
Show More Show More
Bronchitis
21
Lung Disorder
12
Bronchial Hyperreactivity
10
Pneumonia
10
Bronchitis Chronic
9
Drug Use For Unknown Indication
8
Hypersensitivity
7
Sinusitis
7
Chest Discomfort
6
Pulmonary Fibrosis
6
Respiratory Disorder
6
Chronic Sinusitis
5
Nasal Polyps
4
Sinus Disorder
4
Multiple Allergies
4
Bronchospasm
4
Bronchiolitis
3
Croup Infectious
3
Nasopharyngitis
3
Eosinophilic Oesophagitis
3
Respiratory Tract Infection
3
Bronchiectasis
3
Prophylaxis
3
Asbestosis
2
Sinus Congestion
2
Asthma Prophylaxis
2
Bronchopulmonary Dysplasia
2
Product Used For Unknown Indication
2
Respiratory Distress
2
Influenza
2
Inflammation
2
Oxygen Saturation Decreased
2
Respiratory Syncytial Virus Infecti...
2
Nasal Congestion
1
Obstructive Airways Disorder
1
Nasal Disorder
1
Increased Bronchial Secretion
1
Dysphonia
1
Polyp
1
Pneumonia Primary Atypical
1
Rhinitis
1
Lung Neoplasm Malignant
1
Postnasal Drip
1
Off Label Use
1
Oesophageal Disorder
1

Drug Labels

LabelLabelerEffective
Pulmicort RespulesAstraZeneca LP02-JUL-10
Pulmicort RespulesPhysicians Total Care, Inc.04-JUN-12
Pulmicort RespulesCardinal Health20-JUN-12

Pulmicort Respules Case Reports

What Pulmicort Respules safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Pulmicort Respules. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Pulmicort Respules.